Global Wound Care market

New Advances in the Wound Care Market

14 January 2020
Pharma

wound care market

In recent years, with the advent of technology, medical practitioners and manufacturers have made huge strides in the wound care market. As one of today’s leading market research and report firms, Visiongain is committed to providing you the most up-to-date information about this exciting industry. That’s why below we’ve collected some of today’s latest products and technologies for your perusal. 

Let’s take a look at some of the most current advances in the wound care market. 

New Products in the Wound Care Market 

This year several exciting new products and applications were released, making dressing wounds easier and more efficient. The first of these, Mepilex Border Flex, was designed to create less waste while also making wound dressing easier by increasing adherence in areas prone to movement. Additionally, it’s also shown to be more comfortable than other dressings and offers a long wear time.

Another exciting product to hit the wound care market this year is Exufiber® Ag+, a gel-fiber dressing used for a variety of wound types, like leg and foot ulcers, cavity wounds, pressure ulcers, and surgical wounds. This dressing inserts a gel to increase healing and make the dressings much easier and less painful to remove 

Lastly, Mepilex Border Sacrum is a dressing used specifically to treat sacral wounds and provide ulcer prevention. Its Deep Defense technology is designed to be both strong and flexible. A host of clinical studies and trials have demonstrated both its effectiveness, as well as its economic features. 

New Research Presented in Fish-Skin Therapy 

In recent years, fish-skin therapy has grown as a new way to treat and dress wounds. This past year, medical fish skin company Kerecis presented their findings at the Symposium on Advanced Wound Care about their use of fish skin for tissue and skin cell regeneration. Their Kerecis Omega3 Wound technology utilizes intact fish skin, which converts the body’s cells and creates living tissue after being grafted onto a wound. 

Since the Kerecis fish skin used for the application is only very gently processed, it maintains most of its features and remains quite similar to human skin, creating the perfect substitute. 

Contact Visiongain for more info about the wound care market! 

If you’re a wound care dressing manufacturer, medical practitioner, or stakeholder in the wound care market, Visiongain would love to hear from you. For more than 20 years we’ve been helping businesses and key leaders get ahead of the competition and solidify their success with in-depth market data. 

Our reports and forecasts use the most current primary and secondary sources to provide you with data you can rely on to make those tough decisions. With more than 1,500 reports spanning more than 18 market verticals, it’s easy to find what you need 

For more information, contact us online today or call +44 (0) 20 7549 9987

Recent News

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

Read

Visiongain Publishes Aptamer Technologies Market Report 2021-2031

Over the last few years, the aptamers has gained widespread attention due to the technological advancements and growth in understanding of the oligonucleotide therapeutics that inhabit the human body.

29 April 2021

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031

Rising prevalence of inflammatory bowel disease including Crohn’s disease and ulcerative colitis; raising awareness for IBD in developing countries; escalating investment in drug R&D by pharmaceutical companies; new product launches worldwide, growing chronic diseases healthcare awareness are some of the major factors that boosting the growth of global IBD drugs market.

29 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever